Silver Grove Financial Group Inc. increased its position in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 21,088.0% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,297 shares of the biotechnology company’s stock after purchasing an additional 5,272 shares during the period. Axon Enterprise makes up 1.0% of Silver Grove Financial Group Inc.’s investment portfolio, making the stock its 14th largest holding. Silver Grove Financial Group Inc.’s holdings in Axon Enterprise were worth $2,238,000 at the end of the most recent quarter.
Several other hedge funds have also bought and sold shares of the business. Keel Point LLC raised its holdings in Axon Enterprise by 4.4% during the first quarter. Keel Point LLC now owns 599 shares of the biotechnology company’s stock worth $254,000 after buying an additional 25 shares during the last quarter. Bridgewater Advisors Inc. lifted its stake in shares of Axon Enterprise by 4.4% in the second quarter. Bridgewater Advisors Inc. now owns 616 shares of the biotechnology company’s stock valued at $352,000 after buying an additional 26 shares in the last quarter. Pinnacle Wealth Planning Services Inc. grew its holdings in shares of Axon Enterprise by 7.8% during the third quarter. Pinnacle Wealth Planning Services Inc. now owns 361 shares of the biotechnology company’s stock valued at $153,000 after buying an additional 26 shares during the last quarter. 44 Wealth Management LLC grew its holdings in shares of Axon Enterprise by 6.0% during the first quarter. 44 Wealth Management LLC now owns 530 shares of the biotechnology company’s stock valued at $225,000 after buying an additional 30 shares during the last quarter. Finally, Owl Creek Wealth Partners LLC grew its holdings in shares of Axon Enterprise by 84.8% during the second quarter. Owl Creek Wealth Partners LLC now owns 85 shares of the biotechnology company’s stock valued at $48,000 after buying an additional 39 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.
Axon Enterprise Stock Performance
NASDAQ AXON opened at $302.54 on Wednesday. Axon Enterprise, Inc has a 1 year low of $291.45 and a 1 year high of $665.07. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.00 and a quick ratio of 2.60. The firm has a market cap of $24.58 billion, a price-to-earnings ratio of 96.97, a PEG ratio of 5.76 and a beta of 1.48. The company has a fifty day moving average price of $430.30 and a 200-day moving average price of $472.14.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its earnings results on Thursday, November 5th. The biotechnology company reported $1.72 EPS for the quarter, missing the consensus estimate of $1.89 by ($0.17). Axon Enterprise had a net margin of 7.56% and a return on equity of 3.87%. The firm had revenue of $908.55 million during the quarter, compared to analysts’ expectations of $934.33 million. During the same quarter in the prior year, the company earned $1.17 EPS. The business’s revenue for the quarter was up 27.8% on a year-over-year basis. As a group, equities research analysts predict that Axon Enterprise, Inc will post 2.10 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several equities research analysts have recently commented on AXON shares. JPMorgan Chase & Co. decreased their target price on shares of Axon Enterprise from $755.00 to $610.00 and set an “overweight” rating for the company in a research report on Friday, November 6th. Morgan Stanley raised their price target on shares of Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. Northcoast Research lifted their price target on Axon Enterprise from $650.00 to $680.00 and gave the company a “buy” rating in a research note on Tuesday, August 11th. The Goldman Sachs Group decreased their price objective on Axon Enterprise from $715.00 to $675.00 and set a “buy” rating for the company in a report on Monday, September 21st. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Axon Enterprise in a report on Tuesday, November 3rd. Thirteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $612.18.
Read Our Latest Stock Report on AXON
Trending Headlines about Axon Enterprise
Here are the key news stories impacting Axon Enterprise this week:
- Positive Sentiment: Axon is investing $1.2 billion for a 37% stake in drone maker Skydio and will become its U.S. public-safety distributor. The deal could broaden Axon’s public-safety technology offering, though its scale also brings investment and execution risks. Axon invests in Skydio
- Positive Sentiment: West Fargo police plan to replace Flock technology with Axon’s system, including new AI features—an example of continued adoption by public-safety customers. West Fargo police adoption
- Positive Sentiment: Despite lowering its price target, Barclays retained an “overweight” rating at $507; Northland reportedly still sees a $540 target after the stock’s steep fall from its August high. These views suggest some analysts see substantial recovery potential, though targets are not guarantees. Northland target outlook
- Neutral Sentiment: A short-interest report lists 0 shares short, despite describing a large increase. The figure appears inconsistent and does not provide a reliable indication of short-selling pressure.
- Negative Sentiment: Axon’s third-quarter adjusted EPS of $1.72 and revenue of about $909 million fell short of estimates. Cautious guidance and roughly $130 million in federal-contract revenue shifting out of 2026 have weighed on the outlook; shares have fallen sharply since the results, while Motorola rose after its earnings beat. Axon versus Motorola after earnings
- Negative Sentiment: Law firms announced investigations into potential securities-law violations. These are allegations under investigation, not findings of wrongdoing, but may add legal and reputational uncertainty for investors. Axon securities investigation notice
Insider Activity
In other Axon Enterprise news, insider Isaiah Fields sold 1,017 shares of Axon Enterprise stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $480.45, for a total transaction of $488,617.65. Following the transaction, the insider owned 56,264 shares of the company’s stock, valued at $27,032,038.80. This trade represents a 1.78% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey C. Kunins sold 9,605 shares of Axon Enterprise stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the transaction, the insider directly owned 97,761 shares in the company, valued at approximately $61,266,818.70. This represents a 8.95% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 37,397 shares of company stock valued at $21,234,034. 4.20% of the stock is currently owned by company insiders.
About Axon Enterprise
Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.
Further Reading
- Five stocks we like better than Axon Enterprise
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
